Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

NCT00146016 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00146016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients
Lead sponsor
UMC Utrecht
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2000
Completion date
January 31, 2007
Enrollment
390
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c